Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry | JACC

In this podcast, Dr. Valentin Fuster discusses a pivotal study on the benefits of early ezetimibe initiation combined with statins after a myocardial infarction, showing improved cardiovascular outcomes. The study’s findings suggest that early combination therapy reduces the risk of major cardiovascular events, urging healthcare pathways to adopt this approach as standard practice for better patient outcomes.